Flagship Bets £100M to Build AI-Driven Drug Companies in UK
, updated First seen Updated Emerging, tapering
Industry
Reported by Global Banking & Finance Review and Reuters2 sources ↓
Reported by Global Banking & Finance Review and Reuters2 sources ↓